EGFR c.2171G>T ;(p.G724V)

Variant ID: 7-55241723-G-T

NM_005228.3(EGFR):c.2171G>T;(p.G724V)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Dynamic recurrence risk and adjuvant chemotherapy benefit prediction by ctDNA in resected NSCLC.

Nature Communications
Qiu, Bin B; Guo, Wei W; Zhang, Fan F; Lv, Fang F; Ji, Ying Y; Peng, Yue Y; Chen, Xiaoxi X; Bao, Hua H; Xu, Yang Y; Shao, Yang Y; Tan, Fengwei F; Xue, Qi Q; Gao, Shugeng S; He, Jie J
Publication Date: 2021-11-19

Variant appearance in text: EGFR: 2171G>T; G724V
PubMed Link: 34799585
Variant Present in the following documents:
  • 41467_2021_27022_MOESM5_ESM.xlsx, sheet 1
View BVdb publication page



Dynamic recurrence risk and adjuvant chemotherapy benefit prediction by ctDNA in resected NSCLC.

Nature Communications
Qiu, Bin B; Guo, Wei W; Zhang, Fan F; Lv, Fang F; Ji, Ying Y; Peng, Yue Y; Chen, Xiaoxi X; Bao, Hua H; Xu, Yang Y; Shao, Yang Y; Tan, Fengwei F; Xue, Qi Q; Gao, Shugeng S; He, Jie J
Publication Date: 2021-11-19

Variant appearance in text: EGFR: 2171G>T; G724V
PubMed Link: 34799585
Variant Present in the following documents:
  • 41467_2021_27022_MOESM5_ESM.xlsx, sheet 1
View BVdb publication page



Prospective experimental treatment of colorectal cancer patients based on organoid drug responses.

Esmo Open
Ooft, S N SN; Weeber, F F; Schipper, L L; Dijkstra, K K KK; McLean, C M CM; Kaing, S S; van de Haar, J J; Prevoo, W W; van Werkhoven, E E; Snaebjornsson, P P; Hoes, L R LR; Chalabi, M M; van der Velden, D D; van Leerdam, M M; Boot, H H; Grootscholten, C C; Huitema, A D R ADR; Bloemendal, H J HJ; Cuppen, E E; Voest, E E EE
Publication Date: 2021-06

Variant appearance in text: EGFR: G724V
PubMed Link: 33887686
Variant Present in the following documents:
  • Main text
View BVdb publication page